Chargement en cours...

Partial and Generalized Lipodystrophy: Comparison of Baseline Characteristics and Response to Metreleptin

CONTEXT: Lipodystrophies are extreme forms of metabolic syndrome. Metreleptin was approved in the United States for generalized lipodystrophy (GLD) but not partial lipodystrophy (PLD). OBJECTIVE: The objective of the study was to test metreleptin's efficacy in PLD vs GLD and find predictors for...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:J Clin Endocrinol Metab
Auteurs principaux: Diker-Cohen, Talia, Cochran, Elaine, Gorden, Phillip, Brown, Rebecca J.
Format: Artigo
Langue:Inglês
Publié: Endocrine Society 2015
Sujets:
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC4422900/
https://ncbi.nlm.nih.gov/pubmed/25734254
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1210/jc.2014-4491
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!